produced by microorganisms such as G. vaginalis,
M. hominis, and Mobiluncus spp, which is
overgrowth in BV. Semen which is alkaline (pH 7.2)
lead to the release of amin from its attachment with
the protein amine and producing a typical odor
(Karim, 2016) (Bradshaw et al., 2013).
The use of vaginal douching is a risk factor for
BV occurence in some women. This study found
that 60% BV patients frequently used vaginal
douching. Washing the vagina (douching) associated
with complaints of dysuria, vaginal discharge, and
itching of the vagina. Vaginal douching, reported to
cause changes in vaginal pH and reduces the
concentration of normal microbiota, facilitating the
growth of opportunistic pathogenic bacteria. The
cessation of this habit may reduce the risk of BV
(Brotman et al., 2008).
Most patients with BV in this study were
classified overweight and obesity. Ventolini et al
showed that obesity increases the risk of BV by 4
fold. Obesity is a mild inflammatory condition,
which affect the mechanisms of immunity in the
vagina. Obesity is an independent risk factor of BV
(Ventolini et al., 2017).
IUD is a contraceptive method that widely used
in patients with BV. Previous study showed that
IUD users had 1.84 times increased risk of BV. The
IUD can alter the normal vaginal flora, and promote
the growth of pathogenic bacteria (Joesof et al.,
2001) (Oduyebo, Anorlu and Ogunsola, 2009).
Analysis on our study showed contrary result, that
IUD was not significantly increases the risk of BV.
Most symptoms that emerged in this study was
excessive vaginal discharge, vaginal odor and
itching. These are in line with previous study
conducted by Abdul Karim and Jusuf Barakbah in
Dermatology Outpatient Clinic Dr. Soetomo
Hospital, where 33.3% of patients experiencing
vaginal odor and 28.6% complained vaginal itching.
Association between accompanying complain and
BV in this study were not significant (p>0.05).
In term of response to BV therapy, 78.4%
showed good result and improved condition, as seen
by negative BV examination. Treatment evaluation
was performed using vaginal swab then assessed by
Nugent score. Metronidazole and Clindamycin are
used as the first line therapy in this study, as
recommended by CDC in 2014 (Oduyebo, Anorlu
and Ogunsola, 2009) (Hoffman et al., 2016).
Metronidazole inhibit anaerobes that support
Gardnerella vaginalis but do not affect Lactobacilli
spp., thereby reducing the risk of late-stage relapse.
Clindamycin is effective alternative drug. All these
antibiotics have been shown to achieve cure rates of
70% to 80% after treatment (Oduyebo, Anorlu and
Ogunsola, 2009). The reccurance rate of BV after
successfull therapy show variety result, starting from
< 3 month until > 1 years, and fortunately 36.4% of
patients never experienced relapse This study did not
found any significant association between all risk
factors and BV.
5 CONCLUSIONS
In this study, it was concluded that the
characteristics of the patients who come to the
Gynecology Outpatient Clinic Dr Soetomo Hospital
complaining excessive vaginal discharge are on
productive age. Most patients diagnosed using
vaginal swab and Nugent score. The treatment of
BV using standard regimen such as Metronidazole
and Clindamycin still proven to be effective, and
able to prevent some relapse.Unfortunately in this
study we could not found any significant association
between all risk factors and BV.
ACKNOWLEDGEMENTS
The authors wish to thank all Resident Obstetric
Gynecolgy and staff in Gynecology Outpatient
Clinic Dr Soetomo Hospital for their dedication in
collecting data, and all the women whose
participation contributed to the success of this study.
REFERENCES
Bilardi J, Walker S, Mooney-Somers J, Temple-Smith M,
McNair R, Bellhouse C, et al. 2016. Women’s views
and experiences of the triggers for onset of bacterial
vaginosis and exacerbating factors associated with
recurrence. PLoS One [Internet]. 11(3):1–15.
Available from:
http://dx.doi.org/10.1371/journal.pone.0150272
Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta
M, Garland SM, et al. 2013. Recurrence of bacterial
vaginosis is significantly associated with posttreatment
sexual activities and hormonal contraceptive use. Clin
Infect Dis, 56(6):777–86.
Brotman RM, Ghanem KG, Klebanoff MA, Taha TE,
Scharfstein DO, Zenilman JM. 2008. The effect of
vaginal douching cessation on bacterial vaginosis: a
pilot study. Am J Obstet Gynecol, 198(6).
Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM,
Schaffer JI, Corton MM. 2016. Gynecologic Infection.
In: Williams Gynecology. 3rd ed. New York:
McGraw-Hill Education LLC; p. 50–2.